Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check4 days agoChange DetectedThe Sweden location entry was updated from Malmo, Sweden, 211 46 to Malmö, Sweden, 211 46 to reflect the correct diacritic spelling used for the Malmö site.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision tag on the page updated from v3.5.2 to v3.5.3, reflecting a newer revision of the documentation.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedSite version updated from v3.5.0 to v3.5.2; no changes to study content or visible page functionality.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and prior Revision: v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.